DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Nihonbashi Life Science HUB

2018 年 10 月 25 日 9:00 上午 - 2018 年 10 月 26 日 6:00 下午

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

7th DIA Cardiac Safety Workshop in Japan

It will be a unique opportunity to learn of and discuss the current state and future directions of CV risk assessments and how to prepare for a new regulatory paradigm.

[Session 5] Strategies for Early Detection of Cardiotoxicity

Session Chair(s)

Atsushi  Sugiyama, MD, PHD

Atsushi Sugiyama, MD, PHD

Professor and Chairman, Department of Pharmacology, Toho University Faculty of Medicine, Japan

Kyosuke  Takeshita, MD, PHD

Kyosuke Takeshita, MD, PHD

Department of Clinical Laboratory Medicine, Saitama Medical Center, Saitama Medical University, Japan

Speaker(s)

Hiroshi  Akazawa, MD, PHD

Hiroshi Akazawa, MD, PHD

Lecturer, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Japan

Integrated Approach to Early Detection of Drug-Induced Cardiotoxicity

Kyosuke  Takeshita, MD, PHD

Kyosuke Takeshita, MD, PHD

Department of Clinical Laboratory Medicine, Saitama Medical Center, Saitama Medical University, Japan

Imaging Biomarkers for Early Detection of Drug-Induced Cardiotoxicity

Najah  Abi-Gerges, PHD

Najah Abi-Gerges, PHD

Vice President, Research & Development , AnaBios Corporation, United States

Preclinical Human Contractility Safety Testing

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。